A Multi-Center, Open Label Study To Evaluate Long Term Safety Of Caduet In Patient With Both Of Hypertension And Hypercholesterolemia, Or With Both Of Angina Pectoris And Hypercholesterolemia.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Amlodipine/atorvastatin (Primary)
- Indications Angina pectoris; Hypercholesterolaemia; Hypertension
- Focus Adverse reactions
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 22 Feb 2012 Actual patient number is 159 according to ClinicalTrials.gov.
- 22 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.